4D Molecular Therapeutics FDMT
NASDAQ FDMT
$12.99 +0.53 (+4.25%)
At close: Nov 11, 2026 · 4:00 PM EST

4D Molecular Therapeutics (FDMT) Other financing activities (as filed) (2020 - 2023)

Updated

Analysis

4D Molecular Therapeutics (FDMT) Other financing activities (as filed) (2020 - 2023) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 4D Molecular Therapeutics 875.59 Mn -584.35 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2023 -472,000.00
Mar 31, 2023 -69,000.00
Dec 31, 2022 -468,000.00
Sep 30, 2022 360,000.00
Jun 30, 2022 -114,000.00
Mar 31, 2022 -246,000.00
Dec 31, 2021 946,000.00
Mar 31, 2021 -946,000.00
Sep 30, 2020 348,000.00
Jun 30, 2020 26,000.00
Mar 31, 2020 -394,000.00
API Access

4D Molecular Therapeutics Other financing activities (as filed) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-financing-activities&ticker=FDMT&period=max&api_key=YOUR_API_KEY